Selected Peer Reviewed Publications:
Updates coming soon.
Cossrow N, Pawaskar M, Witt EA, Ming EE, Victor TW, Herman BK, Wadden TA, Erder MH. Estimating the prevalence of binge eating disorder in a community sample from the United States: Comparing DSM-IV-TR and DSM-5 criteria. Journal of Clinical Psychiatry 77 (8): e968-e974, 2016. http://www.psychiatrist.com/JCP/article/Pages/2016/v77n08/v77n0802.aspx
Toth PP, Potter D, Ming EE. Prevalence of lipid abnormalities in the United States: NHANES 2003-2006. Journal of Clinical Lipidology 6 (4): 325-330, 2012. http://dx.doi.org/10.1016/j.jacl.2012.05.002
Lo Re V, Haynes K, Ming EE, Wood Ives J; Horne LN, Fortier K, Carbonari DM, Hennessy S, Cardillo S, Reese PP, Reddy KR, Margolis D, Apter A, Kimmel SE, Roy J, Freeman CP, Razzaghi H, Holick CN, Esposito DB, Van Staa TJ, Bhullar H, Strom BL. Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies. Pharmacoepidemiology and Drug Safety 21 (11): 1202-1215, 2012. http://onlinelibrary.wiley.com/doi/10.1002/pds.3318/abstract
McAfee AT, Rodriguez LAG, Goettsch WG, Walker AM, Gonzalez-Perez A, Johansson S, Ming EE, Wallander M-A, Herings RMC. Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countries. Minerva Cardioangiologica 58 (6): 611-622, 2010. http://www.minervamedica.it/en/journals/minerva-cardioangiologica/article.php?cod=R05Y2010N06A0611.
Enger C, Gately R, Ming EE, Niemcryk SJ, Williams L, McAfee AT. Pharmacoepidemiology safety study of fibrate and statin concomitant therapy. American Journal of Cardiology 106 (11): 1594-601, 2010. http://www.sciencedirect.com/science/article/B6T10-517K41P-H/2/cc8cec71f9027a4af65422fefb406d19
Motsko SP, Russmann S, Ming EE, Singh VP, Vendiola RM, Jones JK. Effectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events - a cohort study in 395 039 patients from clinical practice. Pharmacoepidemiology and Drug Safety 18: 1214-1222, 2009. http://www3.interscience.wiley.com/journal/122607301/abstract
Ming EE, Davidson MH, Gandhi SK, Marotti M, Miles CG, Ke X, McKenney JM. Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases. Journal of Clinical Lipidology 2: 453-463, 2008. http://dx.doi.org/10.1016/j.jacl.2008.10.007
Cohen L, de Moor C, Eisenberg P, Ming EE, Hu XH. Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Supportive Care in Cancer 15: 497-503, 2007. http://www.springerlink.com/content/9167630211064xg1/fulltext.pdf
McAfee AT, Ming EE, Seeger JD, Quinn SG, Ng EW, Danielson JD, Cutone JA, Fox, JC, Walker, AM. The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy. Pharmacoepidemiology and Drug Safety 15: 444-453, 2006. http://www3.interscience.wiley.com/cgi-bin/fulltext/112651111/PDFSTART
Johansson S, Ming EE, Wallander M-A, Rodriguez LAG, Herings RMC, Goettsch WG, Gonzalez-Perez A, McAfee AT, Walker AM. Rosuvastatin safety: a comprehensive, international pharmacoepidemiology programme. Pharmacoepidemiology and Drug Safety 15: 454-461, 2006. http://www3.interscience.wiley.com/cgi-bin/fulltext/112637310/PDFSTART
Ming EE, Adler GK, Kessler RC, Fogg LF, Matthews KA, Herd JA, Rose RM. Cardiovascular reactivity to work stress predicts subsequent onset of hypertension: the Air Traffic Controller Health Change Study. Psychosomatic Medicine 66: 459-465, 2004. http://www.psychosomaticmedicine.org/cgi/content/abstract/66/4/459
Hu XH, Bull SA, Hunkeler EM, Ming EE, Lee JY, Fireman B, Markson LE. Side effects associated with selective serotonin reuptake inhibitor use for depression: incidence, discomfort and duration. Journal of Clinical Psychiatry 65: 959-965, 2004. http://www.psychiatrist.com/privatepdf/2004/v65n07/v65n0712.pdf
Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, Fireman B. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. Journal of the American Medical Association 288: 1403-1409, 2002. http://jama.ama-assn.org/cgi/reprint/288/11/1403
Gnagy S, Ming EE, Devesa SS, Hartge P, Whittemore AS. Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use. Epidemiology 11: 102-105, 2000. http://www.epidem.com/pt/re/epidemiology/fulltext.00001648-200003000-00004.htm
Conference Participation:
Moch A, Ming E, Horne L, Curley A, Macaron K, Stern L. Molecular breast imaging as an adjunct to mammography and breast ultrasound: our initial experience in the community based tertiary care setting. Women’s Health 2016: the 24th Annual Congress of the Academy of Women’s Health, Washington, DC, USA, April 14-17, 2016. . Published in: Journal of Women’s Health 25 (4): A-24, 2016. http://online.liebertpub.com/doi/pdfplus/10.1089/jwh.2016.29006.abstracts
Pawaskar M, Witt EA, Ming EE, Madhoo M, Erder MH. Estimating the prevalence of DSM-5 attention deficit/hyperactivity disorder (ADHD) in a community sample. American Psychiatric Association 168th Annual Meeting, Toronto, Ontario, Canada, May 16-20, 2015. Published in: Poster Abstract Book, page 362. http://annualmeeting.psychiatry.org/File%20Library/Scientific%20Program/2015PosterAbstractBook.pdf
Cossrow N, Russo LJ, Ming EE, Witt EA, Victor TW, Wadden TA. Estimating the prevalence of binge eating disorder in a community sample: Comparing DSM-IV-TR and DSM-5 criteria. American Psychiatric Association 167th Annual Meeting, New York, New York, USA, May 3-7, 2014. Published in: Poster Abstract Book, page 430. http://www.psychiatry.org//File%20Library/Learn/Archives/am_posters_2014.pdf
Haynes K, Nezamzadeh MS, Carbonari DM, Newcomb C, Roy J, Cardillo S, Leidl KBF, Wood-Ives J, DeVore S, Blak B, Esposito D, Holick C, Van Staa T, Bhullar H, Strom BL, Lo Re V, Ming EE, Hennessy S, Reese PP, Reddy KR, Margolis D, Apter A, Kimmel SE, Freeman CP Razzaghi H. Factors Associated With Utilization of Saxagliptin in the US and UK. International Society for Pharmacoepidemiology (ISPE) 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Montreal, Canada, August 25-28, 2013. Published in: Pharmacoepidemiology and Drug Safety 22 (S1): S470-S471, 2013. http://onlinelibrary.wiley.com/doi/10.1002/pds.3512/pdf
Haynes K, Fortier K, Newcomb C, Roy J, Ming EE, Horne L, Wood Ives J, Strom BL, Lo Re V. Evaluation of methods to estimate days’ supply of oral antidiabetic drugs in The Health Improvement Network (poster). International Society for Pharmacoepidemiology (ISPE) 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Barcelona, Spain, August 23-26, 2012. Published in: Pharmacoepidemiology and Drug Safety 21 (S3): S276, 2012. http://onlinelibrary.wiley.com/doi/10.1002/pds.3324/pdf
Ming EE, Horne LN. Cardiovascular conditions among patients with dyslipidemia (poster). International Society for Pharmacoepidemiology (ISPE) 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, Illinois, US, August 14-17, 2011. Published in: Pharmacoepidemiology and Drug Safety 20 (S1): S23, 2011. http://onlinelibrary.wiley.com/doi/10.1002/pds.2206/pdf
Horne LN, Ming EE, Doyle C. Comparison of patients with and without laboratory results available in a U.S. claims database (poster). International Society for Pharmacoepidemiology (ISPE) 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, Illinois, US, August 14-17, 2011. Published in: Pharmacoepidemiology and Drug Safety 20 (S1): S170, 2011. http://onlinelibrary.wiley.com/doi/10.1002/pds.2206/pdf
Potter D, Horne LN, Kern D, Cziraky MK, Singer J, Ming E. Capture rate of electronically available laboratory test results in the HealthCore Integrated Research Database (poster). International Society for Pharmacoepidemiology (ISPE) 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, Illinois, US, August 14-17, 2011. Published in: Pharmacoepidemiology and Drug Safety 20 (S1): S173, 2011. http://onlinelibrary.wiley.com/doi/10.1002/pds.2206/pdf
Horne L, Ming EE, Karyekar C, Donovan M, Frederich R, Ravichandran S. Saxagliptin in combination with metformin allows more patients to reach a composite end point of HbA1c <7% without weight gain or hypoglycemia. American Diabetes Association 71st Scientific Sessions, San Diego, CA, US, June 24-28, 2011. Published in: Diabetes 60 (suppl 1): A620, 2011. http://diabetes.diabetesjournals.org/content/60/Supplement_1/A582.full.pdf
Horne LN, Ming EE, Doyle C. Availability of laboratory results data in a US claims database (oral presentation). International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, US, May 21-25, 2011. Published in: Value in Health 14 (3): A6, 2011. http://www.valueinhealthjournal.com/article/S1098-3015(11)00176-8/fulltext (slides: http://www.ispor.org/research_study_digest/list.asp?qs=25908)
Toth PP, Potter D, Ming E. Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003-2006 (poster). American Heart Association Scientific Sessions 2010, Chicago, IL, US, November 13-17, 2010. Published in: Circulation 122: A12055, 2010. http://circ.ahajournals.org/cgi/content/meeting_abstract/122/21_MeetingAbstracts/A12055
Toth PP, Potter D, Ming E. Prevalence of uncontrolled lipid abnormalities among adults self-reporting receiving treatment advice: The National Health and Nutrition Examination Survey 2003-2006 (poster). American Heart Association Scientific Sessions 2010, Chicago, IL, US, November 13-17, 2010. Published in: Circulation 122: A19432, 2010. http://circ.ahajournals.org/cgi/content/meeting_abstract/122/21_MeetingAbstracts/A19432
Horne LN, Doyle C, Schladweiler KM, Ming EE. Completeness of laboratory data in a U.S. claims database (poster). International Society for Pharmacoepidemiology (ISPE) 26th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Brighton, UK, August 19-22, 2010. Published in: Pharmacoepidemiology and Drug Safety 19 (S1): S306-S307, 2010. http://onlinelibrary.wiley.com/doi/10.1002/pds.2019/pdf
Brown AS, Ming EE, Wilson PW, Ballantyne C, Haffner SM, Stone N, Foreyt J, Fonarow G, McKenney J, Grundy S. Clinical tool to simplify the identification of high-risk primary prevention patients (oral presentation). American College of Cardiology 57th Annual Scientific Session, Chicago, IL, March 29-April 1, 2008. Published in: Journal of the American College of Cardiology 51 (10 suppl A): A351, 2008. http://www.sciencedirect.com/science/article/B6T18-4S0F18K-8/2/a707c3d7e6bc3e22ad4ac0831e580ea2
Motsko SP, Russmann S, Ming EE, Jones JK. Effectiveness of rosuvastatin compared to other statins for the prevention of fatal and non-fatal cardiovascular events in clinical practice: an epidemiological study (poster). International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 10th Annual European Congress, Dublin, Ireland, October 20-23, 2007. Published in: Value in Health 10 (6): A406, 2007. http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1524-4733.2007.00263_2.x (poster: http://www.ispor.org/research_study_digest/list.asp?qs=15118)
Marotti M, Ming EE, Gandhi SK, Pollack PS. Concomitant use of statins and CYP3A4 inhibitor drugs: data from 380,000 statin users (poster). European Society of Cardiology (ESC) and World Heart Federation (WHF) World Congress of Cardiology 2006, Barcelona, Spain, September 2-6, 2006. Published in: European Heart Journal 27 (suppl 1): 137, 2006. http://eurheartj.oxfordjournals.org/cgi/reprint/27/suppl_1/1
(poster: http://www.posters2view.com/wcc/view.php?nu=89578)
McAfee AT, Ming EE, Seeger JD, Quinn SG, Ng EW, Danielson JD, Cutone JA, Fox JC, Walker AM. Rosuvastatin muscle-related, renal, and hepatic safety is comparable to that of other marketed statins: a retrospective matched cohort study (poster). International Society for Pharmacoepidemiology (ISPE) 22nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Lisbon, Portugal, August 24-27, 2006. Published in: Pharmacoepidemiology and Drug Safety 15(S1): s215, 2006. http://www3.interscience.wiley.com/cgi-bin/fulltext/112733274/PDFSTART.
Davidson MH, Gandhi SK, Ming EE, Ke X, Pollack PS, Marotti MA, McKenney JM. Concomitant prescribing rates of statins and cytochrome P450 3A4 inhibitors and inducers in real-world clinical practice (poster). International Society for Pharmacoepidemiology (ISPE) 22nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Lisbon, Portugal, August 24-27, 2006. Published in: Pharmacoepidemiology and Drug Safety 15 (S1): s289, 2006. http://www3.interscience.wiley.com/cgi-bin/fulltext/112733274/PDFSTART
Ming EE, Miles CG. Impact of the National Cholesterol Education Program Update of the Adult Treatment Panel III Guidelines on the Number of United States Adults Above Low-Density Lipoprotein Cholesterol Goals (poster). American Heart Association 46th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Phoenix, AZ, Mar 2-5, 2006. Published in: Circulation 113 (8): e366-e367, 2006. http://circ.ahajournals.org/cgi/reprint/113/8/e301
McAfee AT, Quinn SG, Danielson JD, Seeger JD, Ming EE, Fox JC, Walker AM. Benefit and Bias of Matching on a Variable Number of Comparators in a Propensity Score Based Model of Statin Initiation (oral presentation). International Society for Pharmacoepidemiology (ISPE) 21st International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Nashville, TN, August 21-24, 2005. Published in: Pharmacoepidemiology and Drug Safety 14 (S2): 61, 2005. http://www3.interscience.wiley.com/cgi-bin/fulltext/110573598/PDFSTART
McAfee AT, Quinn SG, Danielson JD, Seeger JD, Ming EE, Fox JC, Walker AM. A Comparative Study of the Clinical Characteristics of Initiators of Statin Therapy in a Large Managed Care Cohort (oral presentation). International Society for Pharmacoepidemiology (ISPE) 21st International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Nashville, TN, August 21-24, 2005. Published in: Pharmacoepidemiology and Drug Safety 14 (S2): 169, 2005. http://www3.interscience.wiley.com/cgi-bin/fulltext/110573598/PDFSTART
McAfee AT, Quinn SG, Danielson JD, Seeger JD, Ming EE, Fox JC, Walker AM. Effect of Statin Therapy on LDL Cholesterol Levels in a Large Managed Care Cohort (oral presentation). International Society for Pharmacoepidemiology (ISPE) 21st International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Nashville, TN, August 21-24, 2005. Published in: Pharmacoepidemiology and Drug Safety 14 (S2): 201, 2005. http://www3.interscience.wiley.com/cgi-bin/fulltext/110573598/PDFSTART
Cohen L, de Moor C, Eisenberg PD, Kim Y, Ming EE, Kanesan K, Rubenstein EB. Expectations of side effects are associated with health status and fatigue in patients receiving chemotherapy (CT) (poster). 15th International Symposium of the Multinational Association for Supportive Care in Cancer (MASCC). June 18-21, 2003, Berlin, Germany. Published in: Supportive Care in Cancer 11 (6): 403. http://www.springerlink.com/content/68caf8n6nw2fuj44/fulltext.pdf
De Moor C, Cohen L, Eisenberg PD, Kim Y, Ming EE, Rubenstein EB. Patterns of chemotherapy induced nausea and vomiting (CINV) in patients (pts) receiving chemotherapy (CT) (poster). 15th International Symposium of the Multinational Association for Supportive Care in Cancer (MASCC). June 18-21, 2003, Berlin, Germany. Published in: Supportive Care in Cancer 11 (6): 395. http://www.springerlink.com/content/68caf8n6nw2fuj44/fulltext.pdf
Ming EE, Von Dohren D. Chemotherapy-induced nausea and vomiting increases health resource use and costs for cancer patients in the 7 days following chemotherapy (poster). American Society of Clinical Oncology 39th Annual Meeting. May 31-June 3, 2003, Chicago, IL. Published in: Proceedings of the American Society of Clinical Oncology 22: 2003 (abstr 2141). http://www.asco.org/ASCOv2/Meetings/Abstracts?vmview=abst_detail_view&confID=23&abstractID=102257.
Hunkeler EM, Bull SA, Lee JY, Galligan DF, Hu H, Ming E, Markson L. Better communication may improve SSRI adherence (poster). 8th Annual HMO Research Network Conference. April 9-10, 2002, Long Beach, CA. http://www.hmoresearchnetwork.org/archives/2002abst/02_pa_20.pdf
Hunkeler E, Bull S, Lee J, Galligan D, Hu H, Ming E, Markson L. Better communication may improve SSRI adherence (poster). 40th Annual Meeting of the American College of Neuro-Psychopharmacology. December 9-13, 2001, Waikoloa, HI.
Ming EE, Rose RM, Kessler RC. Effect of job loss among participants of the air traffic controller strike (oral presentation). 127th Annual Meeting and Exposition of the American Public Health Association. November 7-11, 1999, Chicago, IL.
Ming EE, Rose RM, Kessler RC. Prospective associations between physical and mental disorders in a sixteen-year follow-up of the Air Traffic Controllers Health Change Study (roundtable). 127th Annual Meeting and Exposition of the American Public Health Association. November 7-11, 1999, Chicago, IL.
Ming EE. A moment in the history of American mental health policy: forced sterilization of mentally retarded children and adolescents (oral presentation). 127th Annual Meeting and Exposition of the American Public Health Association. November 7-11, 1999, Chicago, IL.
Lascher SM, Bright RA, Ming EE, Marinac-Dabic D. Predictors of device assisted vaginal deliveries (poster). American College of Epidemiology, Annual Meeting. September 23, 1997, Cambridge, MA.
Invited Presentations:
“Becoming an Independent Epidemiology Consultant: Legal and Logistic Considerations Before Hanging Your Shingle.” Pharmacoepidemiology Rounds, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA. January 15, 2016.
“Pharmacoepidemiology in Action: The CRESTORTM (rosuvastatin) Pharmacoepidemiology Program” and “Avandia and the Meta-Analysis Method.” Pharmacoepidemiology (course QARA 5573). Temple University School of Pharmacy, Fort Washington, PA. November 7, 2013, November 13, 2014, December 2, 2015.
Moderator, “Round Table Discussion – Strategies for Optimizing Signal Detection in Clinical Trials.” Safety Signal Detection and Evaluation (CBI Conference). Philadelphia, PA, March 20-21, 2013. http://www.cbinet.com/conference/pc13115
“The Avandia Story.” Grand Rounds, Delaware County Memorial Hospital, Drexel Hill, PA. April 25, 2009.
“Confounding by Indication.” Introduction to Pharmacoepidemiology (course). 23rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Quebec City, Canada, August 18, 2007. http://pharmacoepi.org/meetings/23rdconf/index.cfm
Updates coming soon.
Cossrow N, Pawaskar M, Witt EA, Ming EE, Victor TW, Herman BK, Wadden TA, Erder MH. Estimating the prevalence of binge eating disorder in a community sample from the United States: Comparing DSM-IV-TR and DSM-5 criteria. Journal of Clinical Psychiatry 77 (8): e968-e974, 2016. http://www.psychiatrist.com/JCP/article/Pages/2016/v77n08/v77n0802.aspx
Toth PP, Potter D, Ming EE. Prevalence of lipid abnormalities in the United States: NHANES 2003-2006. Journal of Clinical Lipidology 6 (4): 325-330, 2012. http://dx.doi.org/10.1016/j.jacl.2012.05.002
Lo Re V, Haynes K, Ming EE, Wood Ives J; Horne LN, Fortier K, Carbonari DM, Hennessy S, Cardillo S, Reese PP, Reddy KR, Margolis D, Apter A, Kimmel SE, Roy J, Freeman CP, Razzaghi H, Holick CN, Esposito DB, Van Staa TJ, Bhullar H, Strom BL. Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies. Pharmacoepidemiology and Drug Safety 21 (11): 1202-1215, 2012. http://onlinelibrary.wiley.com/doi/10.1002/pds.3318/abstract
McAfee AT, Rodriguez LAG, Goettsch WG, Walker AM, Gonzalez-Perez A, Johansson S, Ming EE, Wallander M-A, Herings RMC. Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countries. Minerva Cardioangiologica 58 (6): 611-622, 2010. http://www.minervamedica.it/en/journals/minerva-cardioangiologica/article.php?cod=R05Y2010N06A0611.
Enger C, Gately R, Ming EE, Niemcryk SJ, Williams L, McAfee AT. Pharmacoepidemiology safety study of fibrate and statin concomitant therapy. American Journal of Cardiology 106 (11): 1594-601, 2010. http://www.sciencedirect.com/science/article/B6T10-517K41P-H/2/cc8cec71f9027a4af65422fefb406d19
Motsko SP, Russmann S, Ming EE, Singh VP, Vendiola RM, Jones JK. Effectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events - a cohort study in 395 039 patients from clinical practice. Pharmacoepidemiology and Drug Safety 18: 1214-1222, 2009. http://www3.interscience.wiley.com/journal/122607301/abstract
Ming EE, Davidson MH, Gandhi SK, Marotti M, Miles CG, Ke X, McKenney JM. Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases. Journal of Clinical Lipidology 2: 453-463, 2008. http://dx.doi.org/10.1016/j.jacl.2008.10.007
Cohen L, de Moor C, Eisenberg P, Ming EE, Hu XH. Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Supportive Care in Cancer 15: 497-503, 2007. http://www.springerlink.com/content/9167630211064xg1/fulltext.pdf
McAfee AT, Ming EE, Seeger JD, Quinn SG, Ng EW, Danielson JD, Cutone JA, Fox, JC, Walker, AM. The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy. Pharmacoepidemiology and Drug Safety 15: 444-453, 2006. http://www3.interscience.wiley.com/cgi-bin/fulltext/112651111/PDFSTART
Johansson S, Ming EE, Wallander M-A, Rodriguez LAG, Herings RMC, Goettsch WG, Gonzalez-Perez A, McAfee AT, Walker AM. Rosuvastatin safety: a comprehensive, international pharmacoepidemiology programme. Pharmacoepidemiology and Drug Safety 15: 454-461, 2006. http://www3.interscience.wiley.com/cgi-bin/fulltext/112637310/PDFSTART
Ming EE, Adler GK, Kessler RC, Fogg LF, Matthews KA, Herd JA, Rose RM. Cardiovascular reactivity to work stress predicts subsequent onset of hypertension: the Air Traffic Controller Health Change Study. Psychosomatic Medicine 66: 459-465, 2004. http://www.psychosomaticmedicine.org/cgi/content/abstract/66/4/459
Hu XH, Bull SA, Hunkeler EM, Ming EE, Lee JY, Fireman B, Markson LE. Side effects associated with selective serotonin reuptake inhibitor use for depression: incidence, discomfort and duration. Journal of Clinical Psychiatry 65: 959-965, 2004. http://www.psychiatrist.com/privatepdf/2004/v65n07/v65n0712.pdf
Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, Fireman B. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. Journal of the American Medical Association 288: 1403-1409, 2002. http://jama.ama-assn.org/cgi/reprint/288/11/1403
Gnagy S, Ming EE, Devesa SS, Hartge P, Whittemore AS. Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use. Epidemiology 11: 102-105, 2000. http://www.epidem.com/pt/re/epidemiology/fulltext.00001648-200003000-00004.htm
Conference Participation:
Moch A, Ming E, Horne L, Curley A, Macaron K, Stern L. Molecular breast imaging as an adjunct to mammography and breast ultrasound: our initial experience in the community based tertiary care setting. Women’s Health 2016: the 24th Annual Congress of the Academy of Women’s Health, Washington, DC, USA, April 14-17, 2016. . Published in: Journal of Women’s Health 25 (4): A-24, 2016. http://online.liebertpub.com/doi/pdfplus/10.1089/jwh.2016.29006.abstracts
Pawaskar M, Witt EA, Ming EE, Madhoo M, Erder MH. Estimating the prevalence of DSM-5 attention deficit/hyperactivity disorder (ADHD) in a community sample. American Psychiatric Association 168th Annual Meeting, Toronto, Ontario, Canada, May 16-20, 2015. Published in: Poster Abstract Book, page 362. http://annualmeeting.psychiatry.org/File%20Library/Scientific%20Program/2015PosterAbstractBook.pdf
Cossrow N, Russo LJ, Ming EE, Witt EA, Victor TW, Wadden TA. Estimating the prevalence of binge eating disorder in a community sample: Comparing DSM-IV-TR and DSM-5 criteria. American Psychiatric Association 167th Annual Meeting, New York, New York, USA, May 3-7, 2014. Published in: Poster Abstract Book, page 430. http://www.psychiatry.org//File%20Library/Learn/Archives/am_posters_2014.pdf
Haynes K, Nezamzadeh MS, Carbonari DM, Newcomb C, Roy J, Cardillo S, Leidl KBF, Wood-Ives J, DeVore S, Blak B, Esposito D, Holick C, Van Staa T, Bhullar H, Strom BL, Lo Re V, Ming EE, Hennessy S, Reese PP, Reddy KR, Margolis D, Apter A, Kimmel SE, Freeman CP Razzaghi H. Factors Associated With Utilization of Saxagliptin in the US and UK. International Society for Pharmacoepidemiology (ISPE) 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Montreal, Canada, August 25-28, 2013. Published in: Pharmacoepidemiology and Drug Safety 22 (S1): S470-S471, 2013. http://onlinelibrary.wiley.com/doi/10.1002/pds.3512/pdf
Haynes K, Fortier K, Newcomb C, Roy J, Ming EE, Horne L, Wood Ives J, Strom BL, Lo Re V. Evaluation of methods to estimate days’ supply of oral antidiabetic drugs in The Health Improvement Network (poster). International Society for Pharmacoepidemiology (ISPE) 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Barcelona, Spain, August 23-26, 2012. Published in: Pharmacoepidemiology and Drug Safety 21 (S3): S276, 2012. http://onlinelibrary.wiley.com/doi/10.1002/pds.3324/pdf
Ming EE, Horne LN. Cardiovascular conditions among patients with dyslipidemia (poster). International Society for Pharmacoepidemiology (ISPE) 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, Illinois, US, August 14-17, 2011. Published in: Pharmacoepidemiology and Drug Safety 20 (S1): S23, 2011. http://onlinelibrary.wiley.com/doi/10.1002/pds.2206/pdf
Horne LN, Ming EE, Doyle C. Comparison of patients with and without laboratory results available in a U.S. claims database (poster). International Society for Pharmacoepidemiology (ISPE) 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, Illinois, US, August 14-17, 2011. Published in: Pharmacoepidemiology and Drug Safety 20 (S1): S170, 2011. http://onlinelibrary.wiley.com/doi/10.1002/pds.2206/pdf
Potter D, Horne LN, Kern D, Cziraky MK, Singer J, Ming E. Capture rate of electronically available laboratory test results in the HealthCore Integrated Research Database (poster). International Society for Pharmacoepidemiology (ISPE) 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, Illinois, US, August 14-17, 2011. Published in: Pharmacoepidemiology and Drug Safety 20 (S1): S173, 2011. http://onlinelibrary.wiley.com/doi/10.1002/pds.2206/pdf
Horne L, Ming EE, Karyekar C, Donovan M, Frederich R, Ravichandran S. Saxagliptin in combination with metformin allows more patients to reach a composite end point of HbA1c <7% without weight gain or hypoglycemia. American Diabetes Association 71st Scientific Sessions, San Diego, CA, US, June 24-28, 2011. Published in: Diabetes 60 (suppl 1): A620, 2011. http://diabetes.diabetesjournals.org/content/60/Supplement_1/A582.full.pdf
Horne LN, Ming EE, Doyle C. Availability of laboratory results data in a US claims database (oral presentation). International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, US, May 21-25, 2011. Published in: Value in Health 14 (3): A6, 2011. http://www.valueinhealthjournal.com/article/S1098-3015(11)00176-8/fulltext (slides: http://www.ispor.org/research_study_digest/list.asp?qs=25908)
Toth PP, Potter D, Ming E. Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003-2006 (poster). American Heart Association Scientific Sessions 2010, Chicago, IL, US, November 13-17, 2010. Published in: Circulation 122: A12055, 2010. http://circ.ahajournals.org/cgi/content/meeting_abstract/122/21_MeetingAbstracts/A12055
Toth PP, Potter D, Ming E. Prevalence of uncontrolled lipid abnormalities among adults self-reporting receiving treatment advice: The National Health and Nutrition Examination Survey 2003-2006 (poster). American Heart Association Scientific Sessions 2010, Chicago, IL, US, November 13-17, 2010. Published in: Circulation 122: A19432, 2010. http://circ.ahajournals.org/cgi/content/meeting_abstract/122/21_MeetingAbstracts/A19432
Horne LN, Doyle C, Schladweiler KM, Ming EE. Completeness of laboratory data in a U.S. claims database (poster). International Society for Pharmacoepidemiology (ISPE) 26th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Brighton, UK, August 19-22, 2010. Published in: Pharmacoepidemiology and Drug Safety 19 (S1): S306-S307, 2010. http://onlinelibrary.wiley.com/doi/10.1002/pds.2019/pdf
Brown AS, Ming EE, Wilson PW, Ballantyne C, Haffner SM, Stone N, Foreyt J, Fonarow G, McKenney J, Grundy S. Clinical tool to simplify the identification of high-risk primary prevention patients (oral presentation). American College of Cardiology 57th Annual Scientific Session, Chicago, IL, March 29-April 1, 2008. Published in: Journal of the American College of Cardiology 51 (10 suppl A): A351, 2008. http://www.sciencedirect.com/science/article/B6T18-4S0F18K-8/2/a707c3d7e6bc3e22ad4ac0831e580ea2
Motsko SP, Russmann S, Ming EE, Jones JK. Effectiveness of rosuvastatin compared to other statins for the prevention of fatal and non-fatal cardiovascular events in clinical practice: an epidemiological study (poster). International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 10th Annual European Congress, Dublin, Ireland, October 20-23, 2007. Published in: Value in Health 10 (6): A406, 2007. http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1524-4733.2007.00263_2.x (poster: http://www.ispor.org/research_study_digest/list.asp?qs=15118)
Marotti M, Ming EE, Gandhi SK, Pollack PS. Concomitant use of statins and CYP3A4 inhibitor drugs: data from 380,000 statin users (poster). European Society of Cardiology (ESC) and World Heart Federation (WHF) World Congress of Cardiology 2006, Barcelona, Spain, September 2-6, 2006. Published in: European Heart Journal 27 (suppl 1): 137, 2006. http://eurheartj.oxfordjournals.org/cgi/reprint/27/suppl_1/1
(poster: http://www.posters2view.com/wcc/view.php?nu=89578)
McAfee AT, Ming EE, Seeger JD, Quinn SG, Ng EW, Danielson JD, Cutone JA, Fox JC, Walker AM. Rosuvastatin muscle-related, renal, and hepatic safety is comparable to that of other marketed statins: a retrospective matched cohort study (poster). International Society for Pharmacoepidemiology (ISPE) 22nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Lisbon, Portugal, August 24-27, 2006. Published in: Pharmacoepidemiology and Drug Safety 15(S1): s215, 2006. http://www3.interscience.wiley.com/cgi-bin/fulltext/112733274/PDFSTART.
Davidson MH, Gandhi SK, Ming EE, Ke X, Pollack PS, Marotti MA, McKenney JM. Concomitant prescribing rates of statins and cytochrome P450 3A4 inhibitors and inducers in real-world clinical practice (poster). International Society for Pharmacoepidemiology (ISPE) 22nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Lisbon, Portugal, August 24-27, 2006. Published in: Pharmacoepidemiology and Drug Safety 15 (S1): s289, 2006. http://www3.interscience.wiley.com/cgi-bin/fulltext/112733274/PDFSTART
Ming EE, Miles CG. Impact of the National Cholesterol Education Program Update of the Adult Treatment Panel III Guidelines on the Number of United States Adults Above Low-Density Lipoprotein Cholesterol Goals (poster). American Heart Association 46th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Phoenix, AZ, Mar 2-5, 2006. Published in: Circulation 113 (8): e366-e367, 2006. http://circ.ahajournals.org/cgi/reprint/113/8/e301
McAfee AT, Quinn SG, Danielson JD, Seeger JD, Ming EE, Fox JC, Walker AM. Benefit and Bias of Matching on a Variable Number of Comparators in a Propensity Score Based Model of Statin Initiation (oral presentation). International Society for Pharmacoepidemiology (ISPE) 21st International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Nashville, TN, August 21-24, 2005. Published in: Pharmacoepidemiology and Drug Safety 14 (S2): 61, 2005. http://www3.interscience.wiley.com/cgi-bin/fulltext/110573598/PDFSTART
McAfee AT, Quinn SG, Danielson JD, Seeger JD, Ming EE, Fox JC, Walker AM. A Comparative Study of the Clinical Characteristics of Initiators of Statin Therapy in a Large Managed Care Cohort (oral presentation). International Society for Pharmacoepidemiology (ISPE) 21st International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Nashville, TN, August 21-24, 2005. Published in: Pharmacoepidemiology and Drug Safety 14 (S2): 169, 2005. http://www3.interscience.wiley.com/cgi-bin/fulltext/110573598/PDFSTART
McAfee AT, Quinn SG, Danielson JD, Seeger JD, Ming EE, Fox JC, Walker AM. Effect of Statin Therapy on LDL Cholesterol Levels in a Large Managed Care Cohort (oral presentation). International Society for Pharmacoepidemiology (ISPE) 21st International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Nashville, TN, August 21-24, 2005. Published in: Pharmacoepidemiology and Drug Safety 14 (S2): 201, 2005. http://www3.interscience.wiley.com/cgi-bin/fulltext/110573598/PDFSTART
Cohen L, de Moor C, Eisenberg PD, Kim Y, Ming EE, Kanesan K, Rubenstein EB. Expectations of side effects are associated with health status and fatigue in patients receiving chemotherapy (CT) (poster). 15th International Symposium of the Multinational Association for Supportive Care in Cancer (MASCC). June 18-21, 2003, Berlin, Germany. Published in: Supportive Care in Cancer 11 (6): 403. http://www.springerlink.com/content/68caf8n6nw2fuj44/fulltext.pdf
De Moor C, Cohen L, Eisenberg PD, Kim Y, Ming EE, Rubenstein EB. Patterns of chemotherapy induced nausea and vomiting (CINV) in patients (pts) receiving chemotherapy (CT) (poster). 15th International Symposium of the Multinational Association for Supportive Care in Cancer (MASCC). June 18-21, 2003, Berlin, Germany. Published in: Supportive Care in Cancer 11 (6): 395. http://www.springerlink.com/content/68caf8n6nw2fuj44/fulltext.pdf
Ming EE, Von Dohren D. Chemotherapy-induced nausea and vomiting increases health resource use and costs for cancer patients in the 7 days following chemotherapy (poster). American Society of Clinical Oncology 39th Annual Meeting. May 31-June 3, 2003, Chicago, IL. Published in: Proceedings of the American Society of Clinical Oncology 22: 2003 (abstr 2141). http://www.asco.org/ASCOv2/Meetings/Abstracts?vmview=abst_detail_view&confID=23&abstractID=102257.
Hunkeler EM, Bull SA, Lee JY, Galligan DF, Hu H, Ming E, Markson L. Better communication may improve SSRI adherence (poster). 8th Annual HMO Research Network Conference. April 9-10, 2002, Long Beach, CA. http://www.hmoresearchnetwork.org/archives/2002abst/02_pa_20.pdf
Hunkeler E, Bull S, Lee J, Galligan D, Hu H, Ming E, Markson L. Better communication may improve SSRI adherence (poster). 40th Annual Meeting of the American College of Neuro-Psychopharmacology. December 9-13, 2001, Waikoloa, HI.
Ming EE, Rose RM, Kessler RC. Effect of job loss among participants of the air traffic controller strike (oral presentation). 127th Annual Meeting and Exposition of the American Public Health Association. November 7-11, 1999, Chicago, IL.
Ming EE, Rose RM, Kessler RC. Prospective associations between physical and mental disorders in a sixteen-year follow-up of the Air Traffic Controllers Health Change Study (roundtable). 127th Annual Meeting and Exposition of the American Public Health Association. November 7-11, 1999, Chicago, IL.
Ming EE. A moment in the history of American mental health policy: forced sterilization of mentally retarded children and adolescents (oral presentation). 127th Annual Meeting and Exposition of the American Public Health Association. November 7-11, 1999, Chicago, IL.
Lascher SM, Bright RA, Ming EE, Marinac-Dabic D. Predictors of device assisted vaginal deliveries (poster). American College of Epidemiology, Annual Meeting. September 23, 1997, Cambridge, MA.
Invited Presentations:
“Becoming an Independent Epidemiology Consultant: Legal and Logistic Considerations Before Hanging Your Shingle.” Pharmacoepidemiology Rounds, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA. January 15, 2016.
“Pharmacoepidemiology in Action: The CRESTORTM (rosuvastatin) Pharmacoepidemiology Program” and “Avandia and the Meta-Analysis Method.” Pharmacoepidemiology (course QARA 5573). Temple University School of Pharmacy, Fort Washington, PA. November 7, 2013, November 13, 2014, December 2, 2015.
Moderator, “Round Table Discussion – Strategies for Optimizing Signal Detection in Clinical Trials.” Safety Signal Detection and Evaluation (CBI Conference). Philadelphia, PA, March 20-21, 2013. http://www.cbinet.com/conference/pc13115
“The Avandia Story.” Grand Rounds, Delaware County Memorial Hospital, Drexel Hill, PA. April 25, 2009.
“Confounding by Indication.” Introduction to Pharmacoepidemiology (course). 23rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Quebec City, Canada, August 18, 2007. http://pharmacoepi.org/meetings/23rdconf/index.cfm
+1 (610) 497-8918 info@epiexcellence.com